Submit Deal

RENEO PHARMACEUTICALS

Summary

Reneo Pharmaceuticals was a clinical-stage company focused on developing therapies for rare genetic mitochondrial diseases and orphan metabolic diseases.

Deals Overview

Total Deals1

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

Mike Grey
Executive Chairman and Founder

Sort

wilson sonsini goodrich & rosati

HQ - Palo Alto

legal advisors (2)

2 Shared Deals

1 For | 1 Opposite

n/a

Total Value

oppenheimer & co

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

leerink partners

HQ - Boston, MA, United States

financial advisors (1)

1 Shared Deal

1 For

n/a

Total Value

covington & burling

HQ - Washington DC

legal advisors to financial advisors (1)

1 Shared Deal

1 For

n/a

Total Value

jones day

HQ - Cleveland

legal advisors (1)

1 Shared Deal

1 For

n/a

Total Value

cooley

HQ - Palo Alto

legal advisors (1)

1 Shared Deal

1 For

n/a

Total Value

evercore

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

n/a

Total Value

lifesci partners

HQ - New York

pr advisors (1)

1 Shared Deal

1 For

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy